Lung Cancer & Early Diagnosis: The Evidence Exists for Lung Screening Guidelines in the EUWhen: 10 Dec 2020
Organiser: European Alliance for Personalised Medicine
Contact: Denis Horgan, Executive Director | phone: +32 4725 35 104 | email: firstname.lastname@example.org
In the wake of several conferences on the subject in recent years and the launch of the European Beating Cancer Plan, the Brussels-based European Alliance for Personalised Medicine (EAPM) will be organising a roundtable on lung-cancer screening in association with the European Respiratory Society, European Radiology Society as well the European Cancer Patient Coalition. The idea is to present a case for the coordinated implementation of lung-cancer screening across the EU Region. The title of the conference is ‘Lung Cancer & Early Diagnosis: The Evidence Exists for Lung Screening Guidelines in the EU and it will take place on December 10th in Brussels (albeit virtually). One of the aims of the conference is to put forward an implementation action plan to facilitate the drawing-up of lung cancer screening guidelines by the EU.
Comprehensive screening programmes have been in place for some time in respect of several other cancers, but not so lung cancer, the biggest killer of all, while guidelines and best practices shared across Member States are urgently required.
It is absolutely clear that it is necessary to formulate an EU Lung Screening strategy involving decision makers and regulators in the arena of public health, to enable the EU and Member States In order to provide a clear focus and to devote sufficient space to analysis, discussions during the conference will concentrate on how
- to assess and address obstacles to the integration of lung cancer screening guidelines into Europe’s healthcare systems
- to identify best practices and their added value
- to outline the potential benefits of Lung Cancer Screening on public health and its impact on policy making
Brussels, 10 December 2020
9.00 CET – 12.50 CET